TearLab acquires AOA’s OcuHub technology platform

Article

TearLab recently closed the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association (AOA).

San Diego, CA-TearLab recently closed the acquisition of the assets of the OcuHub business unit from AOAExcel, Inc., the for-profit subsidiary of the American Optometric Association (AOA).

As of the close of the transaction, the OcuHub purchased assets and business activities will be operated as a wholly owned subsidiary of TearLab. Barry Barresi, OD, OcuHub’s CEO and former executive director of the AOA, will remain CEO of TearLab’s OcuHub subsidiary.

The net purchase was about $1.4 million.

OcuHub, powered by AT&T and Covisint, facilitates a shared care model with a single sign-on portal, which provides secure connectivity among doctors, patients, institutions, and payers. It is a subscription-based service that is HIPAA compliant.

OcuHub also offers electronic medical records software, image management and storage, practice management tools, and marketing programs.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.